1205550-99-7 Usage
General Description
The chemical (E)-2-[2-[2-[5-[4-[tert-butoxycarbonyl[methyl]amino]styryl]pyridine-2-yloxy]ethoxy]ethoxy]ethyl 4-methylbenzenesulfonate is a complex compound with a long chemical name. It consists of a mixture of styryl and pyridine compounds, along with ethoxy and ethyl groups. The inclusion of a tert-butoxycarbonyl group suggests that this chemical may be involved in biological processes such as protein modification or drug design. The presence of a 4-methylbenzenesulfonate group indicates that this compound may also have applications in organic synthesis or medicinal chemistry. Overall, the chemical is a complex and potentially versatile compound with diverse applications in various fields of chemistry and biology.
Check Digit Verification of cas no
The CAS Registry Mumber 1205550-99-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,5,5,5 and 0 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1205550-99:
(9*1)+(8*2)+(7*0)+(6*5)+(5*5)+(4*5)+(3*0)+(2*9)+(1*9)=127
127 % 10 = 7
So 1205550-99-7 is a valid CAS Registry Number.
1205550-99-7Relevant articles and documents
Synthesis of TEG-Substituted 4-(N-Methyl-N-Boc-amino)styrylpyridine as Key Precursor for Monodentate and Multidentate Imaging Agents for A β Plaques
Li, Zhi,Liu, Bo,Duan, Wubiao,Zhu, Lin
, p. 2740 - 2747 (2015)
Triethylene glycol (TEG)-substituted 4-(N-methyl-N-Boc-amino)styrylpyridine, which can serve as key precursor for many monodentate and multidentate imaging agents for Aβ plaques in the human brain, has been readily synthesized with cheap starting materials. Our new method could be employed for mass production of monodentate imaging agent AV-45 and other multidentate imaging agents.
SYNTHESIS OF 18F-RADIOLABELED STYRYLPYRIDINES FROM TOSYLATE PRECURSORS AND STABLE PHARMACEUTICAL COMPOSITIONS THEREOF
-
, (2010/07/10)
The present invention relates to methods of synthesizing 18F-radiolabeled styrylpyridine and its tosylate precursor. The present invention further relates to stable pharmaceutical compositions comprising 18F-radiolabeled styrylpyridine.
